ZEVEX International Introduces EnteraLite in Europe.

Business/Health Editors

SALT LAKE CITY--(BW HealthWire)--Sept. 11, 2000

ZEVEX International, Inc. (NASDAQ NM: ZVXI) today announced that the Company has introduced its EnteraLite(TM) Ambulatory Enteral Feeding Pump at the XXII Congress of the European Society for Parenteral and Enteral Nutrition (ESPEN) being held in Madrid this week. The EnteraLite pump, the first of ZEVEX's proprietary products, is a portable feeding pump for patients requiring nutrition delivery directly into the stomach or intestines. It operates in any orientation, making it particularly appropriate for the pediatric market.

"The European market for ambulatory enteral nutrition supplies is estimated at $20 million annually, which is approximately equal in size to the U.S. market. We look forward to bringing the many benefits of the EnteraLite to patients across Europe, and are pleased to have launched our product at the important ESPEN meeting," commented David McNally, chief executive officer of ZEVEX International. "We plan to roll out this product over the next several months as we conclude discussions with potential distributors. The acceptance of the EnteraLite in the U.S. market has been growing tremendously since it was introduced less than three years ago, and we expect European clinicians to be equally eager to prescribe it to their patients."

Designed for both hospital and home care use, the EnteraLite maintains all industry standard features, as well as new, state-of-the-art improvements available in no other similar product. In addition, it is the lightest, most compact ambulatory enteral feeding pump on the market today, possessing unprecedented safety and accuracy in liquid nutrition delivery. Use of the EnteraLite requires disposable feeding bags and tube sets, which ZEVEX also sells.

ZEVEX International designs, manufactures and markets medical devices for enteral nutrition delivery, musculoskeletal evaluation and functional testing. Through its ZEVEX OEM division, the Company also designs and manufactures advanced medical devices including surgical systems, device components and sensors for medical technology companies. For more information, please visit the Company's Web sites at www.zevex.com and www.jtechmed.com.

This news release contains forward-looking statements that involve risks and uncertainties regarding ZEVEX International's operations and future results. Please see the Company's filings with the Securities and Exchange Commission including, without limitation, the Company's Form 10-K and Form 10-Q's, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.